Insider holders · CIK 0000914475
NEUROCRINE BIOSCIENCES INC · NBIX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Kevin Charles GormanDirector | 517,797 | — | 517,797 | Sep 15, 2026 · 5:05 pm EDT | Form 4 |
| Gary A LyonsDirector | 245,697 | — | 245,697 | Nov 5, 2018 · 4:11 pm EST | Form 4 |
| Kyle GanoChief Executive Officer | 154,728 | — | 154,728 | Sep 15, 2026 · 5:05 pm EDT | Form 4 |
| Haig P. BozigianChief Development Officer | 141,639 | — | 141,639 | Feb 8, 2019 · 5:06 pm EST | Form 4 |
| Timothy P CoughlinChief Financial Officer | 137,961 | — | 137,961 | Feb 8, 2017 · 7:39 pm EST | Form 4 |
| Dimitri E. GrigoriadisChief Research Officer | 120,065 | — | 120,065 | Feb 8, 2019 · 5:09 pm EST | Form 4 |
| Eric BenevichChief Commercial Officer | 67,297 | — | 67,297 | Sep 15, 2026 · 5:02 pm EDT | Form 4 |
| Darin LippoldtChief Legal Officer | 56,793 | — | 56,793 | Sep 15, 2026 · 5:06 pm EDT | Form 4 |
| Joseph A MollicaDirector | 56,042 | — | 56,042 | Apr 13, 2017 · 5:32 pm EDT | Form 4 |
| Christopher Flint OBrienFormer Chief Medical Officer | 55,946 | — | 55,946 | Feb 7, 2018 · 6:08 pm EST | Form 4 |
| Corinne H NevinnyDirector | 43,283 | — | 43,283 | May 9, 2018 · 6:12 pm EDT | Form 4 |
| Matt AbernethyChief Financial Officer | 42,808 | — | 42,808 | Sep 15, 2026 · 5:02 pm EDT | Form 4 |
| Richard F PopsDirector | 29,512 | — | 29,512 | Nov 27, 2018 · 6:58 pm EST | Form 4 |
| William H RastetterDirector | 24,750 | — | 24,750 | Jan 26, 2018 · 4:04 pm EST | Form 4 |
| Julie CookeChief Human Resources Officer | 24,025 | — | 24,025 | Sep 15, 2026 · 5:03 pm EDT | Form 4 |
| Jude OnyiaChief Scientific Officer | 22,647 | — | 22,647 | Sep 15, 2026 · 5:07 pm EDT | Form 4 |
| Malcolm Lloyd-SmithChief Regulatory Officer | 19,238 | — | 19,238 | Feb 8, 2019 · 5:11 pm EST | Form 4 |
| Ingrid DelaetChief Regulatory Officer | 18,289 | — | 18,289 | Sep 15, 2026 · 5:04 pm EDT | Form 4 |
| Stephen A SherwinDirector | 14,860 | — | 14,860 | Sep 3, 2026 · 9:39 pm EDT | Form 4 |
| David W. BoyerChief Corp. Affairs Officer | 8,722 | — | 8,722 | Sep 15, 2026 · 5:03 pm EDT | Form 4 |
| Sanjay Chandru KeswaniChief Medical Officer | 3,281 | — | 3,281 | Sep 15, 2026 · 5:05 pm EDT | Form 4 |
| Eiry RobertsChief Medical Officer | 3,143 | — | 3,143 | Jan 10, 2019 · 4:47 pm EST | Form 4 |
| Leslie V NorwalkDirector | 2,430 | — | 2,430 | Jul 30, 2026 · 5:29 pm EDT | Form 4 |
| W Thomas MitchellDirector | 1,000 | — | 1,000 | Jun 24, 2015 · 6:20 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.